Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.
Press releases published on May 30, 2025
TravelingWiki's Jonathan Sutter Cited w/United Airlines, Airbus & Emirates as Leading Challenge to Existing Travel Norms
EIN Presswire
·
May 30, 2025
TravelingWiki CEO Jonathan Sutter has been named as the leading compelling antithetical to the status quo in Autism …
Soft Trim Interior Market to Hit USD 10.5 Billion by 2035, Driven by Premium Comfort and Eco-Friendly Materials
EIN Presswire
·
May 30, 2025
Soft trim interior market driven by growing demand for premium comfort, eco-friendly materials, and enhanced vehicle aesthetics. NEWARK, DE, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- The Automotive Soft Trim Interior Materials Market is poised …
TSplus Releases Server Monitoring Version 6 – A Major Step Forward in Remote Infrastructure Management
GlobeNewswire
·
May 30, 2025
PARIS, May 30, 2025 (GLOBE NEWSWIRE) -- TSplus is proud to announce the official release of Server Monitoring Version 6, a major upgrade that reinforces its commitment to providing powerful and user-friendly tools for IT professionals managing remote …
Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics™ immunotherapy plus nivolumab at ASCO 2025
GlobeNewswire
·
May 30, 2025
Survival in 20 patients with MSS/pMMR mCRC at a median follow-up of 15.4 months was 40% at 12 months; median survival is currently 11.3 months Survival has currently reached plateau, with 34% (7/20) of patients still alive 80% of patients treated with …
Communiqué de presse : L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO
GlobeNewswire
·
May 30, 2025
L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO L’étude AERIFY-1 a atteint son objectif principal, à savoir une réduction statistiquement significative des exacerbations modérées ou sévères chez …
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
GlobeNewswire
·
May 30, 2025
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided …